Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: EMG at Performing ULTN 1 in Breast Cancer Patients [NA]
Clinical trial record notes the completed status of a study evaluating electromyography (EMG) in a physiotherapy-related context for breast …
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer [Phase 2]
Open-label Phase 2 window-of-opportunity study evaluating ganetespib in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase I/II study of vorinostat with paclitaxel and bevacizumab in metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Clinical Value of 89Zr-trastuzumab PET [Phase 2]
Phase 2 clinical trial evaluating the clinical value of 89Zr-trastuzumab PET imaging in metastatic breast cancer; study completed.
-
CLINICAL_TRIALS withdrawal · 2015-11-05Clinical Trial Update: Evaluation of Nutrition and Metabolism in Breast Cancer Patients [NA]
The clinical trial evaluating nutrition and metabolism in breast cancer patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-11-05Clinical Trial Update: TME Neoadjuvant Breast Registry
Clinical trial registry update for the TME Neoadjuvant Breast Registry sponsored by Targeted Medical Education; status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Treatment With Ribavirin for Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating ribavirin for metastatic breast cancer was terminated, with no published results reported.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of trastuzumab (Herceptin) and tanespimycin in patients with solid tumors and HER2-pos…
-
CLINICAL_TRIALS research · 2015-11-04Clinical Trial Update: Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors
Clinical trial update on systemic DKK1 changes during estrogen fluctuations in postmenopausal breast cancer patients treated with aromatase …
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating intravenous Alvespimycin in HER2-positive breast cancer was terminated.
-
CLINICAL_TRIALS research · 2015-11-02Clinical Trial Update: Breast Surgery Recovery: The Clinical and Psychosocial Impact of THEYA Recovery Range [NA]
This document provides an update on a clinical trial evaluating the THEYA Recovery Range for breast surgery recovery and its clinical and ps…
-
CLINICAL_TRIALS withdrawal · 2015-11-02Clinical Trial Update: Nipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCT [NA]
A pilot randomized controlled trial investigating nipple delay prior to nipple-sparing mastectomy for breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer [Phase 1, Phase 2]
Terminated Phase 1b/2 study of buparlisib (BKM120) in combination with trastuzumab for HER2-positive metastatic breast cancer, with results …
-
CLINICAL_TRIALS research · 2015-10-30Clinical Trial Update: Expressive Writing and Adjustment to Metastatic Breast Cancer
This clinical trial update notes that a study evaluating expressive writing and psychological adjustment in people with metastatic breast ca…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating AMG 386 (trebananib) with paclitaxel, with or without bevacizumab, as first-line therapy for HER2-negative breast c…
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes
This clinical trial update reports the prevalence of genetic polymorphisms in genes coding for enzymes that metabolize tamoxifen.
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients
An observational study evaluating how patients with estrogen receptor-positive breast cancer respond to tamoxifen.
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: Nerveblocks for Persistent Pain After Breast Cancer Surgery [Phase 3]
Phase 3 trial evaluating nerve blocks for persistent neuropathic pain after breast cancer surgery; current status/results are not provided i…
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer [Phase 1]
Phase 1 study evaluating a telomerase inhibitor to reverse trastuzumab resistance in HER2-positive breast cancer has completed.
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: Facilitating Adjustment in Low Income Black Women With Breast Cancer [NA]
This clinical trial update summarizes a study focused on helping low-income Black women cope with breast cancer.
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
SWOG trial S9719 studied gene damage after chemotherapy in women with stage II or III breast cancer. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: The Myocet/Lapatinib Study. ICORG 10-03, V5 [Phase 1, Phase 2]
This update notes the termination of ICORG 10-03, a Phase 1/2 study of Myocet in combination with lapatinib for HER2-positive metastatic bre…
-
CLINICAL_TRIALS research · 2015-10-23Clinical Trial Update: Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients [NA]
A completed clinical trial from the Federal University of Maranhão evaluated whether exercise training affects autonomic modulation in breas…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery [NA]
The clinical trial NCT02073045 evaluating intensive education to increase understanding of lymphedema in patients undergoing breast cancer s…
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of Interventions [NA]
Clinical trial update reporting on Stage Two evaluation of interventions to prevent or treat nail toxicity in women receiving taxane chemoth…